S.A. Mason’s Bristol-Myers Squibb BMY Stock Holding History

S.A. Mason’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$211K	Buy	3,669 +2	+0.1%	+$115	0.06%	212
2026 Q1	$222K	Buy	3,667 +51	+1%	+$2.97K	0.08%	192
2025 Q4	$195K	Buy	3,616 +3	+0.1%	+$144	0.08%	194
2025 Q3	$163K	Buy	3,613 +2	+0.1%	+$93	0.07%	202
2025 Q2	$167K	Sell	3,611 -498	-12%	-$24.4K	0.08%	185
2025 Q1	$251K	Buy	4,109 +181	+5%	+$10.6K	0.13%	148
2024 Q4	$222K	Sell	3,928 -158	-4%	-$8.83K	0.12%	161
2024 Q3	$211K	Buy	4,086 +2	+0%	+$94	0.11%	163
2024 Q2	$170K	Buy	4,084 +2	+0%	+$89	0.1%	172
2024 Q1	$221K	Buy	4,082 +152	+4%	+$7.74K	0.13%	147
2023 Q4	$202K	Sell	3,930 -999	-20%	-$52.4K	0.14%	151
2023 Q3	$286K	Sell	4,929 -331	-6%	-$20.3K	0.21%	120
2023 Q2	$365K	Hold	5,260	–	–	0.26%	103
2023 Q1	$365K	Sell	5,260 -129	-2%	-$9.1K	0.26%	103
2022 Q4	$388K	Sell	5,389 -185	-3%	-$13.9K	0.29%	95
2022 Q3	$396K	Buy	5,574 +1	+0%	+$73	0.31%	89
2022 Q2	$429K	Buy	5,573 +50	+0.9%	+$3.81K	0.31%	92
2022 Q1	$403K	Buy	5,523 +501	+10%	+$33.6K	0.25%	103
2021 Q4	$313K	Buy	5,022 +1	+0%	+$59	0.19%	125
2021 Q3	$297K	Buy	5,021 +1	+0%	+$66	0.2%	129
2021 Q2	$335K	Buy	5,020 +1	+0%	+$65	0.23%	119
2021 Q1	$317K	Buy	5,019 +301	+6%	+$18.7K	0.24%	114
2020 Q4	$293K	Buy	4,718 +1	+0%	+$61	0.24%	110
2020 Q3	$284K	Sell	4,717 -7	-0.1%	-$421	0.27%	99
2020 Q2	$278K	Buy	4,724 +1	+0%	+$60	0.29%	95
2020 Q1	$263K	Buy	4,723 +109	+2%	+$6.66K	0.32%	92
2019 Q4	$296K	Buy	+4,614	New	+$264K	0.28%	101

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

S.A. Mason's BMY Position: Q2 2026 in Review

S.A. Mason increased its Bristol-Myers Squibb (BMY) stake by 0.05% in Q2 2026, buying an estimated $115 and bringing the position to 3,669 shares worth $211K. The position accounts for 0.06% of the portfolio, ranked #212.

S.A. Mason first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $429K in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

S.A. Mason held 3,669 shares of Bristol-Myers Squibb worth $211K as of Q2 2026.
S.A. Mason bought 2 Bristol-Myers Squibb shares in Q2 2026, an estimated $115.
Bristol-Myers Squibb made up 0.06% of S.A. Mason's portfolio in Q2 2026, its #212 holding.
S.A. Mason first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
S.A. Mason's Bristol-Myers Squibb position peaked at $429K in Q2 2022.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on S.A. Mason's 13F filing for Q2 2026, filed 31 Jul 2026.